Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25382610
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Blood+Cancer+J
2014 ; 4
(11
): e260
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Nimbolide targets BCL2 and induces apoptosis in preclinical models of
Waldenströms macroglobulinemia
#MMPMID25382610
Chitta K
; Paulus A
; Caulfield TR
; Akhtar S
; Blake MK
; Ailawadhi S
; Knight J
; Heckman MG
; Pinkerton A
; Chanan-Khan A
Blood Cancer J
2014[Nov]; 4
(11
): e260
PMID25382610
show ga
Neem leaf extract (NLE) has medicinal properties, which have been attributed to
its limonoid content. We identified the NLE tetranorterpenoid, nimbolide, as
being the key limonoid responsible for the cytotoxicity of NLE in various
preclinical models of human B-lymphocyte cancer. Of the models tested,
Waldenströms macroglobulinemia (WM) cells were most sensitive to nimbolide,
undergoing significant mitochondrial mediated apoptosis. Notably, nimbolide
toxicity was also observed in drug-resistant (bortezomib or ibrutinib) WM cells.
To identify putative targets of nimbolide, relevant in WM, we used
chemoinformatics-based approaches comprised of virtual in silico screening,
molecular modeling and target-ligand reverse docking. In silico analysis revealed
the antiapoptotic protein BCL2 was the preferential binding partner of nimbolide.
The significance of this finding was further tested in vitro in RS4;11
(BCL2-dependent) tumor cells, in which nimbolide induced significantly more
apoptosis compared with BCL2 mutated (Jurkat BCL2(Ser70-Ala)) cells. Lastly,
intraperitoneal administration of nimbolide in WM tumor xenografted mice,
significantly reduced tumor growth and IgM secretion in vivo, while modulating
the expression of several proteins as seen on immunohistochemistry. Overall, our
data demonstrate that nimbolide is highly active in WM cells, as well as other
B-cell cancers, and engages BCL2 to exert its cytotoxic activity.